We found that AZD3463 could effectively block both WT and mutant ALK signaling in vitro through blocking the downstream PI3K/AKT/mTOR pathway in all four tested NB cell lines in as short as a few minutes. The gene discussed is AKT1; the disease is neuroblastoma.